CRISPR Therapeutics
IPOZug, Switzerland · Founded 2013 · $410.5M raised
- Headquarters
- Zug
- Employees
- 201–500
- Founded
- 2013
- Business Model
- B2B
- Total Funding
- $410.5M
- Last Round
- $280.0M Venture RoundFeb 2024
- Rounds
- 4
About
Life sciences company
Summary
CRISPR Therapeutics is a Biotech company based in Zug, Switzerland, founded in 2013. It has raised $410.5M in total across 4 rounds, most recently a $280.0M Venture Round round in Feb 2024. Investors include SR One, EcoR1 Capital and Franklin Templeton.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...